EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Prognosis impact of multiple novel lymphocyte‐based inflammatory indices in patients with initially diagnosed coronary artery disease

Yi Gao, Geng Bai iD, Yuqing Li, Bo Yu, Ziqiang Guo, Xiaolin Chen, Tong Liu, Guangping Li

Immunity, Inflammation and Disease · 2024

DOI: 10.1002/iid3.1340 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Immunity, Inflammation and Disease, 2024. Verfasst von Yi Gao und 7 weiteren Autor:innen. Beteiligte Einrichtung: Tianjin Key Laboratory of Ionic-Molecular Function of Cardiovascular Disease, Department of Cardiology, Tianjin Institute of Cardiology, The Second H…. Hauptthemen laut MEDLINE: Coronary Artery Disease, Lymphocytes, Inflammation, Biomarkers. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Tianjin Key Medical Discipline (specialty) Construction Project.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

This study aimed to evaluate six novel lymphocyte‐based inflammatory markers (neutrophil‐lymphocyte ratio, monocyte‐lymphocyte ratio, platelet‐lymphocyte ratio [PLR], systemic immune inflammation index [SII], systemic inflammatory response index, and systemic immune inflammation response index [SIIRI]) in patients with newly diagnosed coronary artery disease [CAD].

Methods

A total of 959 patients newly diagnosed with CAD and underwent diagnostic coronary angiography were enrolled in this study and followed for major adverse cardiovascular events (MACEs), including cardiovascular death, nonfatal myocardial infarction, and nonfatal stroke. The best cutoff value was used to compare the six indicators. Cox risk regression analysis evaluated the relationship between novel lymphocyte‐based inflammatory markers and MACEs in newly diagnosed CAD patients.

Results

During a mean follow‐up period of 33.3 ± 9.9 months, 229 (23.9%) MACEs were identified. Multivariate Cox regression analysis showed that only SIIRI (hazard ratio [HR]: 5.853; 95% confidence interval [CI]: 4.092–8.371; p < .001) and PLR (HR: 1.725; 95% CI: 1.214–2.452; p = .002) were independent predictors of MACEs. Nevertheless, following the adjustment for covariates, only the SIIRI was found to be a significant predictor MACEs and its corresponding specific endpoint occurrences. The predictive ability of the model was improved when six different inflammatory markers were added to the basic model established by traditional risk factors, namely, the C‐index increased, and the SIIRI increased most significantly (AUC: 0.778; 95% CI: 0.743–0.812; p < .001). However, among the six novel inflammatory markers, only SIIRI had improved net reclassification improvement (NRI) and integrated discrimination improvement (IDI) (NRI: 0.187; 95% CI: 0.115–0.259, p < .001. IDI: 0.135; 95% CI: 0.111–0.159, p < .001), which was superior to the basic model established by traditional risk factors.

Conclusions

SIIRI is independent predictor of MACEs in newly diagnosed CAD patients. SIIRI was superior to other measures in predicting MACEs. The combination of SIIRI and traditional risk factors can more accurately predict MACEs.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Coronary Artery DiseaseLymphocytesInflammationBiomarkersHumansMaleFemaleMiddle AgedPrognosisAgedCoronary AngiographyNeutrophilsBlood PlateletsRisk FactorsFollow-Up Studies

Stichwörter der Autor:innen

coronary artery diseasemajor adverse cardiovascular eventsnovel inflammatory markerspercutaneous coronary intervention

Substanzen

Biomarkers

Autor:innen und Institutionen

  • Tianjin Key Laboratory of Ionic-Molecular Function of Cardiovascular Disease, Department of Cardiology, Tianjin Institute of Cardiology, The Second Hospital of Tianjin Medical University, Tianjin, China.

ORCID-Profile: Geng Bai

Förderung

  • National Natural Science Foundation of China
  • Tianjin Key Medical Discipline (specialty) Construction Project

Zitieren

APA

Gao, Y., Bai, G., Li, Y., Yu, B., Guo, Z., Chen, X., Liu, T., & Li, G. (2024). Prognosis impact of multiple novel lymphocyte‐based inflammatory indices in patients with initially diagnosed coronary artery disease. Immunity, Inflammation and Disease. https://doi.org/10.1002/iid3.1340

Vancouver

Gao Y, Bai G, Li Y, Yu B, Guo Z, Chen X, et al. Prognosis impact of multiple novel lymphocyte‐based inflammatory indices in patients with initially diagnosed coronary artery disease. Immunity, Inflammation and Disease. 2024. doi:10.1002/iid3.1340

BibTeX
@article{Gao2024,
  author = {Gao, Yi and Bai, Geng and Li, Yuqing and Yu, Bo and Guo, Ziqiang and Chen, Xiaolin and Liu, Tong and Li, Guangping},
  title = {Prognosis impact of multiple novel lymphocyte‐based inflammatory indices in patients with initially diagnosed coronary artery disease},
  journal = {Immunity, Inflammation and Disease},
  year = {2024},
  doi = {10.1002/iid3.1340}
}
Kostenlos starten →